DE60141014D1 - Verfharen zur herstellung von herpes-simplex-virus-amplikons, die resultierenden amplikons und ihre verwendung - Google Patents

Verfharen zur herstellung von herpes-simplex-virus-amplikons, die resultierenden amplikons und ihre verwendung

Info

Publication number
DE60141014D1
DE60141014D1 DE60141014T DE60141014T DE60141014D1 DE 60141014 D1 DE60141014 D1 DE 60141014D1 DE 60141014 T DE60141014 T DE 60141014T DE 60141014 T DE60141014 T DE 60141014T DE 60141014 D1 DE60141014 D1 DE 60141014D1
Authority
DE
Germany
Prior art keywords
hsv
amplicon particles
herpes simplex
simplex virus
amplicon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60141014T
Other languages
English (en)
Inventor
Howard Federoff
William Bowers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Rochester
Original Assignee
University of Rochester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Rochester filed Critical University of Rochester
Application granted granted Critical
Publication of DE60141014D1 publication Critical patent/DE60141014D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16641—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
DE60141014T 2000-05-23 2001-05-23 Verfharen zur herstellung von herpes-simplex-virus-amplikons, die resultierenden amplikons und ihre verwendung Expired - Lifetime DE60141014D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20649700P 2000-05-23 2000-05-23
PCT/US2001/016682 WO2001089304A1 (en) 2000-05-23 2001-05-23 Method of producing herpes simplex virus amplicons, resulting amplicons, and their use

Publications (1)

Publication Number Publication Date
DE60141014D1 true DE60141014D1 (de) 2010-02-25

Family

ID=22766659

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60141014T Expired - Lifetime DE60141014D1 (de) 2000-05-23 2001-05-23 Verfharen zur herstellung von herpes-simplex-virus-amplikons, die resultierenden amplikons und ihre verwendung

Country Status (7)

Country Link
EP (1) EP1289368B1 (de)
AT (1) ATE454039T1 (de)
AU (2) AU6486201A (de)
CA (1) CA2410536A1 (de)
DE (1) DE60141014D1 (de)
DK (1) DK1289368T3 (de)
WO (1) WO2001089304A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60141976D1 (de) 2000-11-29 2010-06-10 Univ Rochester Helfervirus-freie herpesvirus-amplifikatpartikel und deren verwendungen
US8092791B2 (en) 2001-05-23 2012-01-10 University Of Rochester Method of producing herpes simplex virus amplicons, resulting amplicons, and their use
EP1532254A4 (de) * 2002-05-31 2006-05-10 Univ Rochester Virusfreie helfer-herpesvirus-amplicon-teilchen und ihre verwendungszwecke
US7399851B2 (en) 2002-07-25 2008-07-15 Dana Farber Cancer Institute, Inc. Composition and method for imaging cells
CA2513559A1 (en) * 2003-01-23 2004-08-05 University Of Rochester Herpesvirus amplicon particles
WO2005082415A2 (en) 2004-02-25 2005-09-09 Dana Farber Cancer Institute, Inc. Inhibitors of insulin-like growth factor receptor-1 for inhibiting tumor cell growth
US7968762B2 (en) 2004-07-13 2011-06-28 Van Andel Research Institute Immune-compromised transgenic mice expressing human hepatocyte growth factor (hHGF)
AU2006258099A1 (en) * 2005-06-03 2006-12-21 University Of Rochester Herpes virus-based compositions and methods of use in the prenatal and perinatal periods
US20110039916A1 (en) * 2006-06-06 2011-02-17 University Of Rochester Helper Virus-Free Herpesvirus Amplicon Particles and Uses Thereof
EP2101813B1 (de) 2006-11-27 2014-04-02 Patrys Limited Neues glykosyliertes zielpeptid in neoplastischen zellen
JP5624884B2 (ja) 2007-08-02 2014-11-12 ノビミューンエスアー 抗ｒａｎｔｅｓ抗体およびその使用の方法
EP2727996A1 (de) 2008-11-06 2014-05-07 The Johns-Hopkins University Behandlung von chronisch-entzündlichen Atemwegserkrankungen mit NP1 Inhibitoren
EP2258858A1 (de) 2009-06-05 2010-12-08 Universitätsklinikum Freiburg Für LSD1 transgenisches Tiermodell für Krebs
CA2785996C (en) 2009-12-07 2021-04-13 The Johns Hopkins University Sr-bi as a predictor of human female infertility and responsiveness to treatment
ES2941502T3 (es) 2016-05-13 2023-05-23 4D Molecular Therapeutics Inc Variantes de cápsides de virus adenoasociado y procedimientos de utilización de las mismas
FI3684423T3 (fi) 2017-09-20 2023-06-15 4D Molecular Therapeutics Inc Adenoassesioidun viruksen kapsidivariantteja ja niiden käyttömenetelmiä
PE20210915A1 (es) 2017-11-27 2021-05-19 4D Molecular Therapeutics Inc Capsides variantes de virus adenoasociados y su uso para inhibir la angiogenesis
EP4349852A1 (de) 2021-05-28 2024-04-10 Shanghai Regenelead Therapies Co., Ltd. Rekombinantes adeno-assoziiertes virus mit veränderlichem kapsid und anwendung davon

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990009441A1 (en) * 1989-02-01 1990-08-23 The General Hospital Corporation Herpes simplex virus type i expression vector

Also Published As

Publication number Publication date
ATE454039T1 (de) 2010-01-15
AU2001264862B2 (en) 2006-03-30
EP1289368A1 (de) 2003-03-12
DK1289368T3 (da) 2010-05-03
AU6486201A (en) 2001-12-03
EP1289368B1 (de) 2010-01-06
EP1289368A4 (de) 2006-04-19
CA2410536A1 (en) 2001-11-29
WO2001089304A1 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
DE60141014D1 (de) Verfharen zur herstellung von herpes-simplex-virus-amplikons, die resultierenden amplikons und ihre verwendung
NZ504367A (en) Vector for tissue-specific replication and gene expression
AU2220800A (en) Compositions and methods for packaging of alphavirus vectors
WO1995027071A3 (en) An adenovirus supervector system
AU2975699A (en) Methods for producing a polypeptide in a bacillus cell
DK1349926T3 (da) Komplementerende cellelinier
ATE234933T1 (de) Verfahren zur herstellung von d-aminosäuren durch direkte gärung
AU4940096A (en) Host cell expressing reduced levels of a metalloprotease and methods using the host cell in protein production
GB2209764A (en) Recombinant vaccinia virus
ATE369430T1 (de) Methoden zur herstellung von nukleotidintegrasen
EP0213894A3 (de) Defektive Viruspartikelimpfstoffe und Verfahren zur Anwendung derselben
WO1994013812A3 (en) Novel entomopoxvirus genes, proteins and methods of use thereof
Sawicki et al. Alphavirus positive and negative strand RNA synthesis and the role of polyproteins in formation of viral replication complexes
DK0749489T3 (da) Ekspressionskassette, der omfatter en promotor stammende fra pho4-genet fra Schizosaccharomyces pombe
DK599788D0 (da) Fremstilling af proteiner
JPH08509369A (ja) 哺乳類株化細胞および糖蛋白の生産方法
CA2390049A1 (en) Control of post-transcriptional gene silencing in plants
JPS58995A (ja) ウイルス蛋白の合成
ATE456662T1 (de) Genetisch veränderte dendritische zellen, die mit adeno-assoziiertem virus transduziert wurden, verfahren zur herstellung dieser zellen und ihre verwendungen
PT93614A (pt) Estirpe de levedura melhorada para a producao de proteinas heterologas maduras,em particular hirudina, e processo para a preparacao da hirudina correspondente
AU2002212555A1 (en) Yeast derived vaccine against ipnv
AUPM772494A0 (en) Improvements in production of proteins in host cells
ATE439432T1 (de) Verfahren zur herstellung von säugetier-trypsinen
EP1310551A4 (de) Virus-ähnliche mikrokugeln und verfahren für deren herstellung(15.02.02)
EP0981537B1 (de) Infektiöser klon für menschlichen parainfluenzavirus-typ

Legal Events

Date Code Title Description
8364 No opposition during term of opposition